PHMMF Dividends Insights

PHMMF pays dividends yearly. Last paid amount was $0.91 at Jun 27, 2025. As of today, dividend yield (TTM) is 0.85%.

Dividend Score Premium

Avoid dividend cuts
with our Dividend Score

Start 7-Day Free Trial

Safety Rating

AI Analysis AI Analysis of PHMMF
AI-Powered Dividend Insights

Built on AI-powered analysis of yield strength, recent news, payout trends, and 10-year dividend growth consistency.

Dividend Yield Range

The Dividend Yield Range is the range of values in which a stock’s dividend yield has fluctuated within a specified period, often a year. It represents the variation between the highest and lowest dividend yields observed during that time frame.
AI Analysis AI Analysis of PHMMF
AI-Powered Market Insights
New!
Dividend Analysis

Key Stats

Dividend Yield (TTM) 0.85%
Frequency Yearly
1Y Growth 0%
Payout Ratio 0
Amount Per Share $0.91
Pharma Mar SA has not yet announced its next dividend date. Last payment date was: Jun 27, 2025.

PHMMF Dividend Payout History

To ensure a understanding of PHMMF's dividend performance, consider examining the historical payout ratios and how they align with the company's earnings. Fluctuations in payout amounts may reflect changes in the company's dividend policy or earnings stability.


# Declaration Date Ex-Date Pay Date Amount Yield
1 Jun 25, 2025 Jun 25, 2025 Jun 27, 2025 $0.91 1.12%
2 Jun 12, 2024 Jun 12, 2024 Jun 14, 2024 $0.563 1.81%
3 Jun 07, 2023 Jun 07, 2023 Jun 07, 2023 $0.695 1.76%
4 Jul 13, 2022 Jul 13, 2022 Jul 13, 2022 $0.652 0.85%
5 Apr 28, 2021 Apr 28, 2021 Apr 28, 2021 $0.725 0.658%
6 Jun 26, 2020 Jun 26, 2020 Jun 30, 2020 $0.436 0.415%
7 Jul 09, 2008 Jul 09, 2008 Jul 17, 2008 $0.0948 0%
8 Jul 14, 2004 Jul 14, 2004 Jul 14, 2004 $0.148 0%
9 Jul 02, 2003 Jul 02, 2003 Jul 02, 2003 $0.139 0%
10 Jun 03, 2002 Jun 03, 2002 Jun 03, 2002 $0.112 0%
Requires Login
Login

Dividend Sustainability

With a moderate Dividend Sustainability Score (DSS), the company may sustain its dividends, but continuous monitoring is advised for any financial shifts. Its high Dividend Growth Potential Score (DGPS) signals potential dividend growth. Overall, the dividend outlook is mixed, and merits close monitoring of both financial strength and growth prospects.

DSS - Sustainability score

Average (60.47%)

DSGP - Growth potential

Increase likely (28.54%)

PHMMF Dividend Calculator

Dividend Calculator is designed to forecast the potential returns from PHMMF dividends based on your individual investment size or the number of shares you own. Simply enter your total investment amount to see the cumulative dividend payment you could receive over a specified period.
Read how to invest in PHMMF stock here.

FAQ

What factors can affect the amount of PHMMF's dividend payments?
The amount of PHMMF's dividends can fluctuate based on several factors, including the company's financial performance, earnings, cash flow, capital requirements, and overall market conditions. Changes in PHMMF sector's trends, interest rate shifts, and the company's operational adjustments can also influence dividend decisions.

Can dividends from PHMMF stock be automatically reinvested?
If PHMMF offers a Dividend Reinvestment Plan (DRIP), shareholders may have the option to automatically reinvest dividends to purchase additional shares. Please check with your brokerage for the availability and details of such a plan. Here's an easy guide on how to buy PHMMF stock.

How often does PHMMF pay dividend?
Pharma Mar SA (PHMMF) pays dividends yearly. The most recent payout was on Jun 27, 2025.

How much does PHMMF pays per share?
The last recorder (Jun 25, 2025) dividend per share was $0.91.

What is PHMMF dividend growth rate?
Over the last year, Pharma Mar SA has witnessed growth rate of 0% . Looking back over the past 3 years, this growth rate has been 9.39%. Furthermore, examining the past 5 years, Pharma Mar SA has maintained an average Dividends Per Share Growth Rate of 6.89%.
Click to get the best stock tips daily for free!
ABOUT PHARMA MAR SA
Pharma Mar SA
Pharma Mar, S.A., a biopharmaceutical company, engages in the research, development, production, and commercialization of bio-active principles of marine origin for use in oncology in Spain, Italy, Germany, Ireland, rest of EU, the United States, and internationally. The company operates through three segments: Oncology, Diagnostics, and RNA interference. It develops and commercializes Yondelis for the treatment of soft tissue sarcomas and for ov...
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
18.86% May 06
GLBE
$31.61
5.35% May 05
SAP
$172.39
10.69% May 05
W
WCLD
$27.34
27.18% Apr 29
ADBE
$243.57
7.61% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE